Mucosal and systemic immune responses induced after oral delivery of vaccinia virus recombinants

Vaccine

Volumn 17, Issue 9-10, 1999, Pages 1074-1083

  Gherardi, M Magdalena ^a   Esteban, Mariano ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

HIV env; Mucosal immunity; Vaccinia virus

Indexed keywords

VACCINIA VACCINE; VIRUS VECTOR;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; HELPER CELL; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VACCINIA VIRUS;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, VIRAL; BETA-GALACTOSIDASE; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CERCOPITHECUS AETHIOPS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE PRODUCTS, ENV; HELA CELLS; HIV-1; HUMANS; IMMUNITY, MUCOSAL; LYMPH NODES; LYMPHOCYTE ACTIVATION; MESENTERY; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; SPLEEN; VACCINIA VIRUS; VIRAL PROTEINS;

EID: 0033525799     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00324-7     Document Type: Article

References (40)

1. Elson C.O. In defense of mucosal surfaces. Regulation and manipulation of the mucosal immune system. Adv Exp Med Biol. 412:1997;85-373.
2. Holmgren J., Brantzaeg P., Capron A., Francotte M., Kilian M., Kraehenbuhl J.P., Lehner T., Seljelid R. European Commission COST/STD Initiative. Report of the expert panel VI. Concerted efforts in the field of mucosal immunology. Vaccine. 14:1996;64-644.
3. Moss B. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proc Natl Acad Sci USA. 93:1996;8-11341.
4. Moss B., Smith G.L., Gerin J.L., Purcell R.H. Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature. 311:1984;9-67.
5. Smith G.L., Murphy B.R., Moss B. Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemaglutinin gene and induces resistance to influenza virus infection in hamsters. Proc Natl Acad Sci USA. 80:1983;9-7155.
6. Jones L., Giavedoni L., Saliki J.T., Brown C., Mebus C., Yilma T. Protection of goats against peste des petis rumiants with a vaccinia virus double recombinant expressing the F and H genes of rinderpest virus protects cattle against rinderpest and causes no pock lesions. Proc Natl Acad Sci USA. 88:1991;5-8011.
7. Hochstein-Mintzel V., Stickl H., Huber H-Ch. Oral immunization against smallpox. Develop Biol Standard. 33:1976;6-260.
8. Brochier B., Boulanger D., Costy F., Pastoret P.P. Towards rabies elimination in Belgium by fox vaccination using a vaccinia-rabies glycoprotein recombinant virus. Vaccine. 12:1994;71-1368.
9. Rupprecht C.E., Kieni M-P. Development of vaccinia-rabies glycoprotein recombinant virus vaccine. Rabies: Developments in Veterinary Virology 1988;:64-335.
10. Kanesaki T., Murphy B.R., Collins P.L., Ogra P.L. Effectiveness of enteric immunization in the development of secretory immunoglobulin A response and the outcome of infection with respiratory syncytial virus. J Virol. 65:1991;657-663.
11. Meitin C.A., Bender B.S., Small P.A. Enteric immunization of mice against influenza with recombinant vaccinia. Proc Natl Acad Sci USA. 91:1994;91-11187.
12. Bender B.S., Rowe C.A., Taylor S.F., Wyatt L.S., Moss B., Small A.P. Oral immunization with a replication deficient recombinant vaccinia virus protects mice against influenza. J Virol. 9:1996;24-6418.
13. Rout P.K., Vrati S. Oral immunization with recombinant vaccinia expressing cell-surface anchored β-hCG induces anti-hCG antibodies and T-cell proliferative response in rats. Vaccine. 15:1997;5-1503.
14. Issekutz T.B. The response of gut associated T lymphocytes to intestinal viral immunization. J Immunol. 133:1984;60-2955.
15. Rodríguez J.F., Rodríguez D., Rodríguez J.R., McGowan E.B., Esteban M. Expression of the firefly luciferase gene in vaccinia virus: a highly sensitive gene marker to follow virus dissemination in tissues of infected animals. Proc Natl Acad Sci USA. 85:1988;71-1667.
16. Rodríguez D., Rodríguez J.R., Rodríguez J.F., Trauber D., Esteban M. Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses. Proc Natl Acad Sci USA. 86:1989;91-1287.
17. Dallo S., Esteban M. Isolation and characterization of attenuated mutants of vaccinia virus. Virology. 159:1987;22-408.
18. Gherardi M.M., Sordelli D.O., Cerquetti M.C. Relevance of local and systemic humoral immunity to the efficacy of immunization with live-attenuated Salmonella enteritidis. Vacc Res. 4:1995;19-27.
19. Rodríguez J.R., Risco C., Carrascosa J.L., Esteban M., Rodríguez D. Characterization of early stages in vaccinia virus membrane biogenesis: implications of the 21-kilodalton protein and a newly identified 15-kilodalton envelope protein. J Virol. 71:(3):1997;33-1821.
20. + T cells using an ELISPOT assay. J of Immunol Methods. 181:1995;45-54.
21. Ogra P.L., Leibovitz E.E., Zhao-Ri G. Oral immunization and secretory immunity to viruses. Curr Top Microbiol Immunol. 146:1989;73-81.
22. Mestecky J. The common mucosal immune system and current strategies for induction of immune response in external secretions. J Clin Immunol. 7:1987;76-265.
23. Moss B. Regulation of Orthopoxvirus gene expression. In: Moyer RW, Turner PC, editors. Current Topics in Microbiology and Immunology. Berlin, Heidelberg: Springer-Verlag, 1990. p. 41-71.
24. London SD. Cytotoxic lymphocytes in mucosal effector sites. In: Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee JR, Bienenstock J, editors. Handbook of mucosal immunology. San Diego: Academic Press, 1994. p. 325-32.
25. London S.D., Rubin D.H., Cebra J.J. Gut mucosal immunization with reovirus serotype 1/L stimulates virus-specific cytotoxic T cell precursors as well as IgA memory cells in Peyer's patches. J Exp Med. 154:1986;47-830.
26. Offit P., Coupar B.E., Voboda Y.M., Jenkins R.J., McCrae M.A., et al. Induction of rotavirus-specific cytotoxic T lymphocytes by vaccinia virus recombinants expressing individual rotavirus genes. Virol. 198:1994;6-10.
27. Finjelman F.D., Holmes J., Katona I.M., Urban J.F., Beckmann M.P., Pank L.S., Schooley K.A., Coffman R.L., Mosmann T.R., Paul W.E. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol. 8:1990;33-303.
28. Stevens T.L., Bossie A., Sanders V.M., Fernandez-Botran R., Coffman R.L., Mosmann T.R., Vitetta E.S. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature. 334:1988;8-255.
29. Nguyen L., Knipe D.M., Finberg R.W. Mechanism of virus induced Ig subclass shifts. J Immunol. 152:1994;84-478.
30. Coutelier J.P., Van der Logt T., Heessen F.W.A., Vink A., Van Snick J. Virally induced modulation of murine IgG antibody subclasses. J Exp Med. 168:1988;8-2373.
31. Major A.S., Cuff C.F. Effects of the route of infection on immunoglobulin G subclasses and specificity of the reovirus-specific humoral immune response. J Virol. 70:1996;74-5968.
32. De Becker G., Sornasse T., Nabavi N., Bazin H., Tielemans F., Urbain J., Leo O., Moser M. Immunoglobulin isotype regulation by antigen-presenting cells in vivo. Eur J Immunol. 24:1994;8-1523.
33. Heeney J.L., Bruck C., Goudsmit J., Montagnier L., Schultz A., Tyrell D., Zolla-Pazner S. Immune correlates of protection from HIV infection and AIDS. Immunol Today. 18:1997;4-8.
34. Global AIDS surveillance. Weekly Epidemiological Record. 72:1997;197-200.
35. Michalek S, Eldridge JH, Curtiss III R, Rosenthal KL. Antigen delivery systems: new approaches to mucosal immunization. In: Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee JR, Bienenstock J. editors. Handbook of mucosal immunology. San Diego: Academic Press, 1994. p. 373-90.
36. Holmgren J., Lycke N., Czerkinsky C. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine. 12:1993;84-1179.
37. Ramsay A.J., Kohonen-Corish M. Interleukin-5 expressed by a recombinant virus vector enhances specific mucosal IgA responses in vivo. Eur J Immunol. 23:1993;5-3141.
38. Ramsay A.J., Husband A.J., Ramshaw I.A., Bao S., Matthei K.I., Koeheler G., Kopf M. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science. 264:1994;3-561.
39. Sutter G., Moss B. Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proc Natl Acad Sci USA. 89:1992;51-10847.
40. Rodríguez D., Esteban M., Rodríguez J.R. Vaccinia virus A17L gene product is essential for an early step in virion morphogenesis. J Virol. 68:1995;8-4640.